Publications by authors named "Steve Kye"

Claim this Profile
S
Selinexor plus ruxolitinib in JAK inhibitor treatment-naïve myelofibrosis: SENTRY Phase 3 study design.
John Mascarenhas, Keri Maher, Raajit Rampal, Prithviraj Bose, Nikolai Podoltsev, Steve Kye

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Farhad Ravandi, Asad Bashey, James Foran, Wendy Stock, Raya Mawad, Steve Kye

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Compound, "FA-1" Isolated from Prunus mume, Protects Human Bronchial Epithelial Cells and Keratinocytes from Cigarette Smoke Extract-Induced Damage.
Andrew J Jang, Ji-Hyeok Lee, Mari Yotsu-Yamashita, Joodong Park, Steve Kye

Sci Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.
Jun Zuo, Steve Kye, Kevin K Quinn, Paige Cooper, Robert Damoiseaux

Antimicrob Agents Chemother· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine is a potent inhibitor of coxsackievirus replication.
Jun Zuo, Kevin K Quinn, Steve Kye, Paige Cooper, Robert Damoiseaux

Antimicrob Agents Chemother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers.
Steve H Kye, Donald P Tashkin, Michael D Roth, Bradley Adams, Wen-Xian Nie

Contemp Clin Trials· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis